Tech Company Financing Transactions
Nexcida Therapeutics Funding Round
Nexcida Therapeutics, based in Menlo Park, raised $2.8 million in investment from Canaan Partners, Frazier Technology Ventures and Vivo Capital.
Transaction Overview
Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$2,750,100
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
70 Willow Rd. 200
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Email Address
Not Recorded
Overview
Nexcida Therapeutics, Inc. operates in the field of infectious disease therapeutics. The company was formerly known as North Bridge I, Inc. The company was founded in 2014.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Socks
Browse more venture capital transactions:
Prev: 6/30/2015: Orbotix venture capital transaction
Next: 6/30/2015: Vtesse venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs